Polymorphous low grade adenocarcinoma: A clinicopathologic study of 164 cases

Cancer

Volumn 86, Issue 2, 1999, Pages 207-219

  Castle, James T ^a   Thompson, Lester D R ^a   Frommelt, R Allen ^a   Wenig, Bruce M ^a   Kessler, Harvey P ^b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Polymorphous low grade adenocarcinoma; Prognosis; Salivary gland carcinoma

Indexed keywords

ALPHA ACTIN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; PROTEIN S 100;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INFILTRATION; CANCER MORTALITY; CELL PROLIFERATION; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; MITOSIS; NEUROTROPISM; PRIORITY JOURNAL; PROGNOSIS; SALIVARY GLAND CARCINOMA;

EID: 0033565909     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990715)86:2<207::AID-CNCR4>3.0.CO;2-Q     Document Type: Article

References (38)

1. Batsakis JG, Pinkston GR, Luna MA, Byers RM, Sciubba JJ, Tillery GW. Adenocarcinomas of the oral cavity: a clinico-pathologic study of terminal duct carcinomas. J Laryngol Otol 1983;97:825-35.
2. Freedman PD, Lumerman H. Lobular carcinoma of intraoral minor salivary gland origin. Report of twelve cases. Oral Surg Oral Med Oral Pathol 1983;56:157-66.
3. Anderson C, Krutchkoff D, Pedersen C, Cartun R, Berman M. Polymorphous low grade adenocarcinoma of minor salivary gland: a clinicopathologic and comparative immunohistochemical study. Mod Pathol 1990;3:76-82.
4. Dardick I, van Nostrand AW. Polymorphous low-grade adenocarcinoma: a case report with ultrastructural findings. Oral Surg Oral Med Oral Pathol 1988;66:459-65.
5. Gnepp DR, Chen JC, Warren C. Polymorphous low-grade adenocarcinoma of minor salivary gland: an immunohistochemical and clinicopathologic study. Am J Surg Pathol 1988;12:461-8.
6. Gnepp DR, el-Mofty S. Polymorphous low-grade adenocarcinoma: glial fibrillary acidic protein staining in the differential diagnosis with cellular mixed tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 1997;83:691-5.
7. Kelsch RD, Bhuiya T, Fuchs A, Gentile P, Kahn MA, Fantasia JE. Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 1997;84:391-9.
8. Norberg LE, Burford-Mason AP, Dardick I. Cellular differentiation and morphologic heterogeneity in polymorphous low-grade adenocarcinoma of minor salivary gland. J Oral Pathol Med 1991;20:373-9.
9. Regezi JA, Zarbo RJ, Stewart JC, Courtney RM. Polymorphous low-grade adenocarcinoma of minor salivary gland: a comparative histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol 1991;71:469-75.
10. Ritland F, Lubensky I, LiVolsi VA. Polymorphous low-grade adenocarcinoma of the parotid salivary gland. Arch Pathol Lab Med 1993;117:1261-3.
11. Rosa JC, Felix A, Fonseca I, Felix M, Scares J. P53 immunoexpression in carcinomas arising in pleomorphic adenomas. Int J Surg Pathol 1996;3:257-62.
12. Rosa JC, Felix A, Fonseca I, Soares J. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation. J Clin Pathol 1997;50:661-3.
13. Vargas H, Sudilovsky D, Kaplan MJ. Mixed tumor, polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. Pathogenic implications and differential diagnosis by Ki-67 (MIB1), BCL2, and S-100 immunohistochemistry. Appl Immunol 1997;5:8-16.
14. Wenig BM, Harpaz N, Del Bridge C. Polymorphous low-grade adenocarcinoma of seromucus glands of the nasopharynx: a report of a case and a discussion of the morphologic and immunohistochemical features. Am J Clin Pathol 1989;92:104-9.
15. Zarbo RJ, Regezi JA, Batsakis JG. S-100 protein in salivary gland tumors: an immunohistochemical study of 129 cases. Head Neck Surg 1986;8:268-75.
16. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
17. Aberle AM, Abrams AM, Bowe R, Melrose RJ, Handlers JP. Lobular (polymorphous low-grade) carcinoma of minor salivary glands: a clinicopathologic study of twenty cases. Oral Surg Oral Med Oral Pathol 1985;60:387-95.
18. Batsakis JG, el-Naggar AK. Terminal duct adenocarcinomas of salivary tissues. Ann Otol Rhinol Laryngol 1991; 100:251-3.
19. Crean SJ, Bryant C, Bennett J, Harris M. Four cases of polymorphous low-grade adenocarcinoma. Int J Oral Maxillofac Surg 1996;25:40-4.
20. Evans HL, Batsakis JG. Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer 1984;15;53:935-42.
21. Frierson HF Jr., Mills SE, Garland TA. Terminal duct carcinoma of minor salivary glands: a nonpapillary subtype of polymorphous low-grade adenocarcinoma. Am J Clin Pathol 1985;84:8-14.
22. Kemp BL, Batsakis JG, el-Naggar AK, Kotliar SN, Luna MA. Terminal duct adenocarcinomas of the parotid gland. J Laryngol Otol 1995;109:466-8.
23. Lucarini JW, Sciubba JJ, Khettry U, Nasser I. Terminal duct carcinoma: recognition of a low-grade salivary adenocarcinoma [see comments]. Arch Otolaryngol Head Neck Surg 1994;120:1010-5.
24. Spiro RH, Koss LG, Hajdu SI, Strong EW. Tumors of minor salivary origin: a clinicopathologic study of 492 cases. Cancer 1973;31:117-29.
25. Vincent SD, Hammond HL, Finkelstein MW. Clinical and therapeutic features of polymorphous low-grade adenocarcinoma. Oral Surg Oral Med Oral Pathol 1994;77:41-7.
26. Wenig BM, Gnepp DR. Polymorphous low-grade adenocarcinoma in minor salivary glands. In: Ellis GE, Auclair PL, editors. Surgical pathology of the salivary glands. Philadelphia: WB Saunders Co., 1991:390-411.
27. Waldron CA, el-Mofty SK, Gnepp DR. Tumors of the intraoral minor salivary glands. A demographic and histologic study of 426 cases. Oral Surg Oral Med Oral Pathol 1988;66: 323-33.
28. Mills SE, Garland TA, Allen MS Jr. Low-grade papillary adenocarcinoma of palatal salivary gland origin. Am J Surg Pathol 1984;8:367-74.
29. Slootweg PJ, Muller H. Low-grade adenocarcinoma of the oral cavity: a comparison between the terminal duct and the papillary type. J Craniomaxillofac Surg 1987;15:359-64.
30. Slootweg PJ. Low-grade adenocarcinoma of the oral cavity: polymorphous or papillary? J Oral Pathol Med 1993;22:327-30.
31. Scally CM, Irwin ST, Nirodi N. Low grade polymorphous adenocarcinoma of a minor salivary gland. J Laryngol Otol 1988;102:284-7.
32. Simpson RH, Clarke TJ, Sarsfield PT, Gluckman PG, Babajews AV. Polymorphous low-grade adenocarcinoma of the salivary glands: a clinicopathological comparison with adenoid cystic carcinoma. Histopathology 1991;19:121-9.
33. Regezi JA, Lloyd RV, Zarbo RJ. Minor salivary gland tumors: a histologic and immunohistochemical study. Cancer 1985; 55:108-15.
34. Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T. Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 1982;46:621-6.
35. Nakazato Y, Ishida Y, Takahashi K, Suzuki K. Immunohistochemical distribution of S-100 protein and glial fibrillary acidic protein in normal and neoplastic salivary glands. Virchows Arch A Pathol Anat Histopathol 1985; 405:299-310.
36. Stead RH, Qizilbash AH, Kontozoglou T, Daya AD, Riddell RH. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component. Hum Pathol 1988;19:32-40.
37. Batsakis JG. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol 1996;27: 561-6.
38. Thomas KM, Cumberworth VL, McEwan J. Orbital and skin metastases in a polymorphous low grade adenocarcinoma of the salivary gland. J Laryngol Otol 1995;109:1222-5.